# Selkirk Pharma

**Canonical:** https://apis.io/providers/selkirk-pharma/  
**Website:** https://www.selkirkpharma.com/  
**APIs profiled:** 0

Selkirk Pharma, Inc. is a privately held U.S. contract development and manufacturing organization (CDMO) in Spokane, Washington, specializing in the aseptic fill/finish of sterile injectable drug products — vaccines, biologics and small molecules — for clinical and commercial supply. Founded in 2018, it operates a purpose-built aseptic campus at 9110 W Granite Avenue in the Pacific Northwest Technology Park, roughly half a mile from Spokane International Airport, running unidirectional personnel and material flow, single-use systems, SKAN isolator technology and Bausch+Strobel VarioSys dose-filling lines rated to about 3,600 vials per hour under EU GMP Annex 1. Services span aseptic filling, in-house analytical chemistry and microbiology, sterility testing, finished-product inspection, regulatory support and supply-chain services, plus a ClinFAST program that compresses fill/finish timelines for clinical-trial material. The build-out drew roughly $150M led by Spokane's Cowles Company with other Washington State investors, and Colleen Dixon was named chief executive in July 2024. Selkirk Pharma sells contract manufacturing capacity, not software: it operates no developer program, publishes no web API, SDK or machine-readable specification, and maintains no public source-code organization. (In this sector "API" ordinarily means active pharmaceutical ingredient; Selkirk fills and finishes drug product and publishes no web API.)

## Kin Score — 2.9 / 100 (minimal)

Scored 2026-09-02 under rubric 0.18.0. Trend: flat (+0.0 from 2.9).

| Facet | Score |
|---|---|
| Discoverability | 46.3 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Selkirk Pharma Domain Security** — DMARC

## Tags

Company, Pharmaceuticals, Contract Manufacturing, CDMO, Sterile Injectables, Aseptic Fill Finish, Biologics, Life Sciences, Clinical Trials, Manufacturing

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/selkirk-pharma/). Scores are computed from the provider's own public artifacts under a published rubric.